tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Dana Flanders, 17 are a BUY (60.71%), 8 are a HOLD (28.57%), 3 are a SELL (10.71%).
Analyst Dana Flanders, currently employed carries an average stock price target met ratio of 69.38% that have a potential upside of 18.32% achieved within 218 days. Previously, Dana Flanders worked at GOLDMAN SACHS.
Dana Flanders’s has documented 50 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on INSM, Insmed at 26-Jul-2023.
Analyst best performing recommendations are on ENDP (ENDO INTERNATIONAL PLC).
The best stock recommendation documented was for HZNP (HORIZON PHARMA PLC) at 7/16/2020. The price target of $64 was fulfilled within 20 days with a profit of $6.94 (12.16%) receiving and performance score of 6.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$12
$2.52 (26.58%)
$8
20 days ago
(07-Nov-2024)
9/12 (75%)
$-0.02 (-0.17%)
19
Sell
$23
1 years 7 days ago
(20-Nov-2023)
1/3 (33.33%)
$14.88 (183.25%)
1
Hold
$15
$5.52 (58.23%)
$29
1 years 6 months 8 days ago
(19-May-2023)
4/8 (50%)
$6.83 (83.60%)
86
Buy
$55
$45.52 (480.17%)
$65
2 years 18 days ago
(09-Nov-2022)
2/8 (25%)
$42.15 (328.02%)
217
Hold
$23
$13.52 (142.62%)
$33
2 years 18 days ago
(09-Nov-2022)
11/15 (73.33%)
$10.15 (78.99%)
166
What Year was the first public recommendation made by Dana Flanders?
